Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Patients who received target doses of beta blocker therapy after a heart attack did not have improved survival over patients receiving lower doses. In the image, propranolol beta-blocker drug crystals

Beta blocker therapy, such as propranolol (crystals pictured), is often given at doses established in early clinical trials rather than at the optimal dose for individual patients

Source  Sidney Moulds / Science Photo Library